France - English - HMA (Heads of Medicines Agencies)

calier portugal, s.a. - ceftiofur hydrochloride 50 mg/ml - suspension for injection - cattle, pigs - ceftiofur

Hungary - English - HMA (Heads of Medicines Agencies)

calier portugal, s.a. - ceftiofur hydrochloride 50 mg/ml - suspension for injection - cattle, pigs - ceftiofur

Italy - English - HMA (Heads of Medicines Agencies)

calier portugal, s.a. - ceftiofur hydrochloride 50 mg/ml - suspension for injection - cattle, pigs - ceftiofur

Netherlands - English - HMA (Heads of Medicines Agencies)

calier portugal, s.a. - ceftiofur hydrochloride 50 mg/ml - suspension for injection - cattle, pigs - ceftiofur

Portugal - English - HMA (Heads of Medicines Agencies)

calier portugal, s.a. - ceftiofur hydrochloride 50 mg/ml - suspension for injection - cattle, pigs - ceftiofur

Romania - English - HMA (Heads of Medicines Agencies)

calier portugal, s.a. - ceftiofur hydrochloride 50 mg/ml - suspension for injection - cattle, pigs - ceftiofur

United Kingdom - English - HMA (Heads of Medicines Agencies)

calier portugal, s.a. - ceftiofur hydrochloride 50 mg/ml - suspension for injection - cattle, pigs - ceftiofur

Spain - English - HMA (Heads of Medicines Agencies)

calier portugal, s.a. - tiamulin hydrogen fumarate 200 mg - solution for injection - pigs - tiamulin

Portugal - English - HMA (Heads of Medicines Agencies)

calier portugal, s.a. - tiamulin hydrogen fumarate 200 mg - solution for injection - pigs - tiamulin

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - diphtheria toxoid; filamentous haemagglutinin (fha); pertactin (prn or 69 kda omp); pertussis toxoid (pt); tetanus toxoid - suspension for injection - diphtheria toxoid nlt 2 iu / 0.5 ml; tetanus toxoid nlt 20 iu / 0.5 ml; filamentous haemagglutinin (fha) 8 mcg / 0.5 ml; pertussis toxoid (pt) 8 mcg / 0.5 ml; pertactin (prn or 69 kda omp) 2.5 mcg / 0.5 ml - tetanus toxoid, combinations with diphtheria toxoid - tetanus toxoid, combinations with diphtheria toxoid - for booster vaccination against diphtheria, tetanus and pertussis of individuals from the age of four years onwards.the administration of boostrix should be based on official recommendations